๐ŸŽ Black Friday: up to 50% off of annual plans
AmCad BioMed Corporation (TPEX:4188)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
11.05
-1.10 (-9.05%)
Nov 20, 2026, 1:30 PM CST

AmCad BioMed Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
26.1630.4453.1165.2661.6385.79
Revenue Growth
-39.87%-42.69%-18.62%5.88%-28.16%34.17%
Gross Profit
5.8710.0232.9341.0238.0560.67
Operating Income
-90.57-87.96-64.66-53.99-64.3-36.77
Net Income
-55.64-55.72-50.58-45.31-53.49-25.54
Earnings Per Share
-0.88-0.88-0.88-0.85-1.01-0.48
EPS Growth
------

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Precise Medical Devices
21.3141.452.951.0552.13
Medical Diagnostic Software
9.1311.712.3610.5833.66
Total
30.4453.1165.2661.6385.79

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
331.64365.22361.71287.27330.84371.05
Total Debt
12.184.7510.8714.3910.3114.73
Net Cash (Debt)
319.46360.47350.84272.88320.53356.32
Net Cash Growth
-15.02%2.75%28.57%-14.87%-10.04%-8.84%
Net Cash Per Share
5.055.696.085.136.026.70

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-51.98-47.06-51.85-41.6-34.19-38.97
Capital Expenditures
--0.37-2.72-0.29-0.61-2.34
Free Cash Flow
-51.98-47.44-54.57-41.89-34.81-41.3
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
22.42%32.93%62.02%62.87%61.73%70.71%
Operating Margin
-346.18%-288.97%-121.77%-82.73%-104.33%-42.86%
Pretax Margin
-275.18%-234.59%-99.57%-66.12%-88.18%-31.34%
Profit Margin
-212.67%-183.06%-95.24%-69.44%-86.79%-29.78%
FCF Margin
-198.67%-155.85%-102.76%-64.20%-56.48%-48.14%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
26.7530.5926.6621.7913.7712.00